Science &
Technology 11/11/02
All the
difference in the world
Medical
promise and political peril in a search for human genetic
variation
BY
NELL BOYCE
At the White House ceremony for the completion of the Human
Genome Project two years ago, President Clinton noted that
"one of the great truths to emerge from this triumphant
expedition inside the human genome is that in genetic terms,
all human beings, regardless of race, are more than 99.9
percent the same." Last week, however, scientists announced
the start of a new genetic map, one that puts the spotlight
not on genetic similarity but on the small differences that
remain.
The
new project, called the HapMap, promises to provide a shortcut
to finding common gene variants linked to major diseases. It
could serve as a tool to help scientists uncover the genetic
factors that put one person at risk of, say, heart disease
while another person gets a higher risk of cancer. But with
the focus now on genetic differences rather than similarities,
"the 800-pound gorilla in the room is race," says Troy Duster,
a New York University sociologist.
The genetic code of DNA contains 3 billion chemical
"letters," and while almost all of the sequence is identical
in every human being, tiny spelling differences turn up every
few hundred letters or so. Just a single letter's difference
can raise a person's risk of disease. But because the total
number of spelling variants could be as high as 10 million,
screening people for all of them to identify ones linked to
diseases would be a daunting task.
Just over a year ago, researchers got a break. They learned
that each individual doesn't inherit a different,
mix-and-match set of variants. Instead, those that are
neighbors on the long DNA molecules get inherited together, in
blocks 10,000 letters or more in length. If scientists had a
map of these inherited blocks and the patterns of genetic
variation found within them, they wouldn't need to sort
through millions of possibilities. Instead, they could screen
just enough to zero in on blocks linked to diseases and start
the gene hunt there.
Francis Collins, head of the National Human Genome Research
Institute, expects this shortcut to have "a profound impact on
the future of medicine." Nine groups in five countries will
work on the HapMap, hoping to complete it in three years at a
cost of $100 million.
Global view. People who are even distantly related
may have similar blocks, called haplotypes. To identify the
widest possible range of blocks, the investigators plan to
study 200 to 400 people whose ancestors separated long ago
during humanity's prehistoric migrations. They'll begin by
looking at Americans with ancestry from Northern and Western
Europe, a group called the Yoruba in Nigeria, and people from
Japan and China.
And that's where the 800-pound gorilla enters the room.
Ethicists worry that the HapMap could easily be misunderstood
as a catalog of racial differences. In fact, most gene
variants will show up in all groups because of their shared
ancestry, although a given variant might be more common in one
group than another. "Being a member of a group doesn't tell
you much, because the overlapping is so great," says David
Altshuler of the Whitehead Institute, whose work helped lead
to the HapMap.
HapMap organizers are still hotly debating whether they
should bury the race issue by putting all their samples in one
big group rather than labeling them by geographic origin. But
some scientists would like to keep the labels because they
think they'll prove useful for gene hunting. It's not just the
subtle variations but also the typical size of the blocks that
could differ between populations. Researchers would like to
start their gene hunts in a population with large blocks, for
example, and then move to groups with smaller ones.
Still, a preview of how findings about genes and race can
get oversimplified came last month. In the New England
Journal of Medicine, researchers reported the discovery of
genetic variants found in both whites and blacks with heart
failure. Yet headlines widely described the finding as "genes
influencing chronic heart failure in blacks," notes Altshuler.
The genes do appear to be more common in blacks, but most
blacks–even those with heart failure–don't have these
variants. And nongenetic factors like diet and access to
healthcare loom large in this disease.
The HapMap will confront scientists and the public with
many more examples of what our genetic differences do–and
don't–mean, says Ellen Wright Clayton of Vanderbilt
University, cochair of the project's ethics board. The
project, she believes, "is really going to force us to face up
to how we can talk about this."